{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:20:05Z","timestamp":1793067605188,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jcyt.2025.01.015","type":"journal-article","created":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T11:15:32Z","timestamp":1738408532000},"page":"835-842","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["iPSC-based cell replacement therapy: from basic research to clinical application"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3642-9186","authenticated-orcid":false,"given":"Jun","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2025.01.015_bib0001","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.jcyt.2025.01.015_bib0002","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41576-019-0100-z","article-title":"Induced pluripotent stem cells in disease modelling and drug discovery","volume":"20","author":"Rowe","year":"2019","journal-title":"Nat Rev Genet"},{"issue":"2","key":"10.1016\/j.jcyt.2025.01.015_bib0003","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.stem.2022.01.007","article-title":"iPSC-based disease modeling and drug discovery in cardinal neurodegenerative disorders","volume":"29","author":"Okano","year":"2022","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jcyt.2025.01.015_bib0004","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.stem.2020.09.014","article-title":"Pluripotent stem cell-based cell therapy-promise and challenges","volume":"27","author":"Yamanaka","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jcyt.2025.01.015_bib0005","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3389\/fncel.2020.00146","article-title":"Neuronal replacement as a tool for basal ganglia circuitry repair: 40 years in perspective","volume":"14","author":"Bj\u00f6rklund","year":"2020","journal-title":"Front Cell Neurosci"},{"issue":"5","key":"10.1016\/j.jcyt.2025.01.015_bib0006","first-page":"683","article-title":"Cardiac regeneration: current therapies-future concepts","volume":"5","author":"Doppler","year":"2013","journal-title":"J Thorac Dis"},{"issue":"6","key":"10.1016\/j.jcyt.2025.01.015_bib0007","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/stem.2357","article-title":"Concise review: the Bystander effect: mesenchymal stem cell-mediated lung repair","volume":"34","author":"Savukinas","year":"2016","journal-title":"Stem Cells"},{"issue":"12","key":"10.1016\/j.jcyt.2025.01.015_bib0008","doi-asserted-by":"crossref","DOI":"10.1002\/bies.202400118","article-title":"The history and status of dopamine cell therapies for Parkinson's disease","volume":"46","author":"Barker","year":"2024","journal-title":"Bioessays"},{"key":"10.1016\/j.jcyt.2025.01.015_bib0009","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1242\/dev.02879","article-title":"Differences in neurogenic potential in floor plate cells along an antero-posterior location: midbrain dopaminergic neurons originate from mesencephalic floor plate cells","volume":"134","author":"Ono","year":"2007","journal-title":"Development"},{"key":"10.1016\/j.jcyt.2025.01.015_bib0010","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nbt.1529","article-title":"Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling","volume":"27","author":"Chambers","year":"2009","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jcyt.2025.01.015_bib0011","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nature10648","article-title":"Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease","volume":"480","author":"Kriks","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jcyt.2025.01.015_bib0012","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.celrep.2012.04.009","article-title":"Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions","volume":"1","author":"Kirkeby","year":"2012","journal-title":"Cell Rep"},{"key":"10.1016\/j.jcyt.2025.01.015_bib0013","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/stem.1152","article-title":"Specification of midbrain dopamine neurons from primate pluripotent stem cells","volume":"30","author":"Xi","year":"2012","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2025.01.015_bib0014","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1101\/gad.1616208","article-title":"Human ES cell-derived neural rosettes reveal a functionally distinct early neural stem cell stage","volume":"22","author":"Elkabetz","year":"2008","journal-title":"Genes Dev"},{"key":"10.1016\/j.jcyt.2025.01.015_bib0015","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/stem.1060","article-title":"Prolonged maturation culture favors a reduction in the tumorigenicity and the dopaminergic function of human ESC-derived neural cells in a primate model of Parkinson's disease","volume":"30","author":"Doi","year":"2012","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2025.01.015_bib0016","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1089\/scd.2015.0394","article-title":"Fail-safe therapy by gamma-ray irradiation against tumor formation by human induced pluripotent stem cell-derived neural progenitors","volume":"25","author":"Katsukawa","year":"2016","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.jcyt.2025.01.015_bib0017","doi-asserted-by":"crossref","first-page":"8011","DOI":"10.1523\/JNEUROSCI.2079-07.2007","article-title":"Serotonin neuron transplants exacerbate L-DOPA-induced dyskinesias in a rat model of Parkinson's disease","volume":"27","author":"Carlsson","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jcyt.2025.01.015_bib0018","doi-asserted-by":"crossref","first-page":"38ra46","DOI":"10.1126\/scitranslmed.3000976","article-title":"Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants","volume":"2","author":"Politis","year":"2010","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.jcyt.2025.01.015_bib0019","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.stemcr.2014.01.013","article-title":"Isolation of human induced pluripotent stem cell-derived dopaminergic progenitors by cell sorting for successful transplantation","volume":"2","author":"Doi","year":"2014","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.jcyt.2025.01.015_bib0020","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1073\/pnas.1501989112","article-title":"Transcriptome analysis reveals transmembrane targets on transplantable midbrain dopamine progenitors","volume":"112","author":"Bye","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jcyt.2025.01.015_bib0021","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.stem.2014.09.017","article-title":"Human ESC-derived dopamine neurons show similar preclinical efficacy and potency to fetal neurons when grafted in a rat model of Parkinson's disease","volume":"15","author":"Grealish","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jcyt.2025.01.015_bib0022","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1016\/j.celrep.2019.08.058","article-title":"hESC-derived dopaminergic transplants integrate into basal ganglia circuitry in a preclinical model of Parkinson's disease","volume":"28","author":"Adler","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.jcyt.2025.01.015_bib0023","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nbt.3124","article-title":"Optogenetics enables functional analysis of human embryonic stem cell-derived grafts in a Parkinson's disease model","volume":"33","author":"Steinbeck","year":"2015","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jcyt.2025.01.015_bib0024","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2410331121","article-title":"TARGET-seq: linking single-cell transcriptomics of human dopaminergic neurons with their target specificity","volume":"121","author":"Fiorenzano","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcyt.2025.01.015_bib0025","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nature23664","article-title":"Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model","volume":"548","author":"Kikuchi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jcyt.2025.01.015_bib0026","doi-asserted-by":"crossref","first-page":"859","DOI":"10.2217\/rme-2018-0095","article-title":"Quality control guidelines for clinical-grade human induced pluripotent stem cell lines","volume":"13","author":"Sullivan","year":"2018","journal-title":"Regen Med"},{"key":"10.1016\/j.jcyt.2025.01.015_bib0027","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.medj.2022.10.003","article-title":"A clinical-grade HLA haplobank of human induced pluripotent stem cells matching approximately 40% of the Japanese population","volume":"4","author":"Yoshida","year":"2023","journal-title":"Med"},{"key":"10.1016\/j.jcyt.2025.01.015_bib0028","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1038\/s41467-020-17165-w","article-title":"Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson's disease","volume":"11","author":"Doi","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcyt.2025.01.015_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2021.102193","article-title":"Generation of nonviral integration-free human iPS cell line KISCOi001-a from normal human fibroblasts, under defined xeno-free and feeder-free conditions","volume":"51","author":"Inzunza","year":"2021","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.jcyt.2025.01.015_bib0030","article-title":"Improved Sendai viral system for reprogramming to naive pluripotency","volume":"2","author":"Kunitomi","year":"2022","journal-title":"Cell Rep Methods"},{"key":"10.1016\/j.jcyt.2025.01.015_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2021.01.004","article-title":"Preclinical efficacy and safety of a human embryonic stem cell-derived midbrain dopamine progenitor product, MSK-DA01","volume":"28","author":"Piao","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jcyt.2025.01.015_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2023.08.014","article-title":"Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PD","volume":"30","author":"Kirkeby","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jcyt.2025.01.015_bib0033","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJMoa1608368","article-title":"Autologous induced stem-cell-derived retinal cells for macular degeneration","volume":"376","author":"Mandai","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcyt.2025.01.015_bib0034","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/s44222-024-00220-2","article-title":"urification technologies for induced pluripotent stem cell therapies","volume":"2","author":"Generali","year":"2024","journal-title":"Nat Rev Bioeng"},{"key":"10.1016\/j.jcyt.2025.01.015_bib0035","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1915872","article-title":"Personalized iPSC-derived dopamine progenitor cells for Parkinson's disease","volume":"382","author":"Schweitzer","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcyt.2025.01.015_bib0036","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1182\/blood.2022017296","article-title":"iPLAT1: the first-in-human clinical trial of iPSC-derived platelets as a phase 1 autologous transfusion study","volume":"140","author":"Sugimoto","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2025.01.015_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2024.09.004","article-title":"Transplantation of chemically induced pluripotent stem-cell-derived islets under abdominal anterior rectus sheath in a type 1 diabetes patient","volume":"187","author":"Wang","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.jcyt.2025.01.015_bib0038","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/978-3-319-18618-4_8","article-title":"Regulatory frameworks for gene and cell therapies in Japan","volume":"871","author":"Maeda","year":"2015","journal-title":"Adv Exp Med Biol"},{"issue":"Suppl 3","key":"10.1016\/j.jcyt.2025.01.015_bib0039","first-page":"29","article-title":"Educating multidisciplinary care teams, patients, and caregivers on CAR T-cell therapy","author":"Beaupierre","year":"2019","journal-title":"J Adv Pract Oncol"},{"issue":"6","key":"10.1016\/j.jcyt.2025.01.015_bib0040","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jcyt.2024.02.021","article-title":"Good manufacturing practice-compliant human induced pluripotent stem cells: from bench to putative clinical products","volume":"26","author":"Novoa","year":"2024","journal-title":"Cytotherapy"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324925000532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324925000532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T21:18:50Z","timestamp":1755551930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324925000532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1465324925000532"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2025.01.015","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"iPSC-based cell replacement therapy: from basic research to clinical application","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2025.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society for Cell & Gene Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}